VANCOUVER, April 24 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced
today that it recorded revenues of $709,302 for the year ended 2006 compared
to $156,879 for the year ended December 31, 2005, and a net loss of $5,647,894
or ($0.13) per share for the year ended December 31, 2006 compared to
$1,117,123 or ($0.03) for the year ended 2005. Additionally, the Company
announced that as of December 31, 2006 it had approximately $6.9 million in
cash and cash equivalents.
Commenting on the 2006 results, Edward Wright, Chief Executive Officer
stated, "What we have learned in the last year is extremely encouraging. Our
growth in 2006 versus 2005 was substantial. Throughout 2006, we focused on
determining the key factors of success and understanding our operating
metrics. As a result, we are better positioned to further scale our business
The Company's December 31, 2006 financial report will be available
April 30th at www.sedar.com
About CRH Medical Corporation:
CRH Medical Corporation is utilizing the first single use, patented,
disposable, hemorrhoid banding system through its Center for Colorectal Health
facilities. CRH Medical is opening its Center for Colorectal Health facilities
in the United States specializing in the treatment of hemorrhoids and
fissures, and colon cancer screening. The Company's goal is to become the
preeminent resource on colorectal health for consumers and medical
professionals in North America.
The information in this news release contains so-called "forward-looking"
statements. These include statements regarding CRH Medical expectations,
beliefs, intentions or strategies for the future, which may be indicated by
words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we
believe", "CRH Medical believes" "management believes" and similar language.
All forward-looking statements are based on CRH Medical current expectations
and are subject to risks and uncertainties and to assumptions made.
For further information, visit the Company's website at
www.crhmedcorp.com or the SEDAR website at www.sedar.com or email us at
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
For further information:
For further information: Investor Contact: Dean Linden (604) 633-1440